Exact Mass: 574.0625066000001
Exact Mass Matches: 574.0625066000001
Found 100 metabolites which its exact mass value is equals to given mass value 574.0625066000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
distigmine bromide
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors
Mangiferin 6'-gallate
Mangiferin 6-gallate is found in fruits. Mangiferin 6-gallate is isolated from leaves of Mangifera indica (mango). Isolated from leaves of Mangifera indica (mango). Mangiferin 6-gallate is found in fruits.
Rubroskyrin
Rubroskyrin is a mycotoxin from the common food storage mould Penicillium islandicu
Gossypetin 8-glucuronide 3-sulfate
C21H18O17S (574.0264698000001)
Gossypetin 8-glucuronide 3-sulfate is found in green vegetables. Gossypetin 8-glucuronide 3-sulfate is isolated from mallow leaves (Malva sylvestris).
Gadodiamide
C16H26GdN5O8 (574.1022406000001)
Gadodiamide is only found in individuals that have used or taken this drug. It is a gadolinium based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. It is commonly marketed under the trade name Omniscan. [Wikipedia]Based on the behavior of protons when placed in a strong magnetic field, which is interpreted and transformed into images by magnetic resonance (MR) instruments. Paramagnetic agents have unpaired electrons that generate a magnetic field about 700 times larger than the protons field, thus disturbing the protons local magnetic field. When the local magnetic field around a proton is disturbed, its relaxation process is altered. MR images are based on proton density and proton relaxation dynamics. MR instruments can record 2 different relaxation processes, the T1 (spin-lattice or longitudinal relaxation time) and the T2 (spin-spin or transverse relaxation time). In magnetic resonance imaging (MRI), visualization of normal and pathological brain tissue depends in part on variations in the radiofrequency signal intensity that occur with changes in proton density, alteration of the T1, and variation in the T2. When placed in a magnetic field, gadodiamide shortens both the T1 and the T2 relaxation times in tissues where it accumulates. At clinical doses, gadodiamide primarily affects the T1 relaxation time, thus producing an increase in signal intensity. Gadodiamide does not cross the intact blood-brain barrier; therefore, it does not accumulate in normal brain tissue or in central nervous system (CNS) lesions that have not caused an abnormal blood-brain barrier (e.g., cysts, mature post-operative scars). Abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadodiamide in lesions such as neoplasms, abscesses, and subacute infarcts.
Garcinia biflavonoid 2
LUTEOSKYRIN
N-[[(2S,3S,4R,5R)-5-[2-Chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-hydroxymethyl]-N-methylformamide
2,2-bis(3,4-dihydroxyphenyl)-3,4,5,6-tetrahydroxyspiro[2H-1-benzofuran-3,9-3,4-dihydro-2H-furo[2,3-h]chromene]-8-one
Patuletin 3-glucoside-7-sulfate
C22H22O16S (574.0628532000001)
Gossypetin 8-glucuronide-3-sulfate
C21H18O17S (574.0264698000001)
3-[5,7-dihydroxy-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydrochromen-3-yl]-5,6,7,8-tetrahydroxy-4-(4-hydroxyphenyl)-3,4-dihydrochromen-2-one
gossypetin 8-O-beta-D-glucuronide 3-sulphate
C21H18O17S (574.0264698000001)
2-[2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4H-1-benzopyran-4-yl]-3,3,4,5,7-pentahydroxyflavone
Bis-<2,5,8-trihydroxy-7-methyl-4,9,10-trioxo-1,2,3,4,9,10-hexahydro-anthryl-(1)> (Rubroskyrin)|Rubroskyrin
8,9b-Bis(3,4-dihydro-3,5,7-trihydroxy-4-oxo-2H-1-benzopyran-2-yl)-4a,9b-dihydrodibenzofuran-3(4H)-one
(2R*,2R*,3R*,3R*)-2,2-bis(2,4-dihydroxyphenyl)-2,2,3,3-tetrahydro-5,5,7,7-tetrahydroxy-4H,4H-3,3-bichromene-4,4-dione|2,2-bisteppogenin
(2R,3S,2S)-2-(3,4-dihydroxyphenyl)-2,2,3,3-tetrahydro-5,5,7,7-tetrahydroxy-2-(3,4-dihydroxyphenyl)-[3,8-Bi-4H-1-benzopyran]-4,4-dione|(2R,3S,2S)-buchananiflavanone
(2R,3S,2S)-buchananiflavanone|(2R,3S,2S)-2-(3,4-dihydroxyphenyl)-2,2,3,3-tetrahydro-5,5,7,7-tetrahydroxy-2-(3,4-dihydroxyphenyl)-[3,8-bi-4H-1-benzopyran]-4,4-dione|3,3,4,4,5,5,7,7-octahydroxy-3,8-biflavanone
olgensisinol D|rel-(2R,3R,7S,8R)-2,7-bis(3,4-dihydroxyphenyl)-8,9-dihydro-4,4,6,8-tetrahydroxyspiro[benzofuran-3(2H),3(2H)-[7H]furo[2,3-f][1]benzopyran]-2-one
1-(2,4,5,8-Tetrahydroxy-7-methyl-9,10-dioxo-1,2,3,9,9a,10-hexahydro-3,9a-cyclo-anthryl-(1))-2,5,8-trihydroxy-4,9,10-trioxo-7-methyl-1,2,3,4,9,10-hexahydro-anthracen (Rubroskyrin)|1-<2,4,5,8-Tetrahydroxy-7-methyl-9,10-dioxo-1,2,3,9,9a,10-hexahydro-3,9a-cyclo-anthryl-(1)>-2,5,8-trihydroxy-4,9,10-trioxo-7-methyl-1,2,3,4,9,10-hexahydro-anthracen (Rubroskyrin)
2-[2-(3,4,5-Trihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4H-1-benzopyran-4-yl]-3,4,5,7-tetrahydroxyflavone
2-[4-[2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-2-yl)phenoxy]phenyl]-3,5,7-trihydroxy-2,3-dihydro-4H-1-benzopyran-4-one
2,2-bis(3,4-dihydroxyphenyl)-3,4,5,6-tetrahydroxyspiro[2H-1-benzofuran-3,9-3,4-dihydro-2H-furo[2,3-h]chromene]-8-one [IIN-based: Match]
Rubroskyrin
Gossypetin 8-glucuronide 3-sulfate
C21H18O17S (574.0264698000001)
Mangiferin 6'-gallate
2,6-Dibromo-4,4-dioctyl-4H-silolo[3,2-b:4,5-b]dithiophene
C24H36Br2S2Si (574.0394296000001)
2,6-Dibromo-4,4-bis(2-ethylhexyl)-4H-silolo[3,2-b:4,5-b]dithiophene
C24H36Br2S2Si (574.0394296000001)
Gadodiamide
C16H26GdN5O8 (574.1022406000001)
V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media
4-pyridin-4-yl-1-[[4-[(4-pyridin-4-ylpyridin-1-ium-1-yl)methyl]phenyl]methyl]pyridin-1-ium,dibromide
C28H24Br2N4 (574.0367583999999)
2,4-Dibromo-6-[(E)-[[(1R,2R)-2-(isoindolin-2-yl)-1,2-diphenylethyl]imino]methyl]phenol
(Dimethylsilylene)bis(2-methyl-4,5-benzoindenyl)zirconium chloride
Osmium bis(2,2-bipyridine)chloride
C20H16Cl2N4Os (574.0357985999999)
2,2-bis(3,4-dihydroxyphenyl)-3,4,5,6-tetrahydroxyspiro[2H-1-benzofuran-3,9-3,4-dihydro-2H-furo[2,3-h]chromene]-8-one
N-[[(2S,3S,4R,5R)-5-[2-Chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-hydroxymethyl]-N-methylformamide
Magnesium 7-hydroxy-8-(phenyldiazenyl)naphthalene-1,3-disulfonate octahydrate
C16H26MgN2O15S2 (574.0625066000001)
(1r,2s,13r,14s,15r,16r,17s,28s)-8,10,14,23,25,28-hexahydroxy-6,21-dimethoxyoctacyclo[14.11.1.0²,¹¹.0²,¹⁵.0⁴,⁹.0¹³,¹⁷.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone
8,14,23,25,28-pentahydroxy-6,21-dimethoxyoctacyclo[14.11.1.0²,¹¹.0²,¹⁵.0⁴,⁹.0¹³,¹⁷.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-4,6,8,19,21,23,25-heptaene-3,10,12,18,27-pentone
2,12'-bis(3,4-dihydroxyphenyl)-4,6,8',11'-tetrahydroxy-2h-5',13'-dioxaspiro[1-benzofuran-3,3'-tricyclo[7.4.0.0²,⁶]tridecane]-1',6',8'-trien-4'-one
8,10,14,23,25,28-hexahydroxy-6,21-dimethoxyoctacyclo[14.11.1.0²,¹¹.0²,¹⁵.0⁴,⁹.0¹³,¹⁷.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone
[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(1,3,6,7-tetrahydroxy-9-oxoxanthen-2-yl)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
2-[2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-yl]-3,5,7-trihydroxy-2,3-dihydro-1-benzopyran-4-one
(2r,3r,11'r,12'r)-2,12'-bis(3,4-dihydroxyphenyl)-4,6,8',11'-tetrahydroxy-2h-5',13'-dioxaspiro[1-benzofuran-3,3'-tricyclo[7.4.0.0²,⁶]tridecane]-1',6',8'-trien-4'-one
(1r,2s,13r,14s,15r,16r,17s,28s)-7,10,14,23,25,28-hexahydroxy-5,21-dimethoxyoctacyclo[14.11.1.0²,¹¹.0²,¹⁵.0⁴,⁹.0¹³,¹⁷.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone
(2s)-6-{6-[(2s)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-2,3-dihydroxyphenyl}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
2,12-bis(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one
(14s,28s)-8,10,14,23,25,28-hexahydroxy-6,21-dimethoxyoctacyclo[14.11.1.0²,¹¹.0²,¹⁵.0⁴,⁹.0¹³,¹⁷.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone
(1s,2r,13s,14r,15s,16s,17r,28s)-5,8,12,14,20,23,27,28-octahydroxy-6,21-dimethyloctacyclo[14.11.1.0²,¹¹.0²,¹⁵.0⁴,⁹.0¹³,¹⁷.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-4,6,8,11,19,21,23,26-octaene-3,10,18,25-tetrone
2,11'-bis(3,4-dihydroxyphenyl)-4,6,7',12'-tetrahydroxy-2h-3',10'-dioxaspiro[1-benzofuran-3,5'-tricyclo[7.4.0.0²,⁶]tridecane]-1',6',8'-trien-4'-one
(3r,11'r,12'r)-2,12'-bis(3,4-dihydroxyphenyl)-4,6,8',11'-tetrahydroxy-2h-5',13'-dioxaspiro[1-benzofuran-3,3'-tricyclo[7.4.0.0²,⁶]tridecane]-1',6',8'-trien-4'-one
1-[2-(3,5-dibromo-4-{3-[(1-hydroxy-2-nitroso-3-phenylprop-1-en-1-yl)amino]propoxy}phenyl)ethyl]pyridin-1-ium
[C25H26Br2N3O3]+ (574.0340786)
(2s,3s)-8-[(2s,3r)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-3-yl]-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-1-benzopyran-4-one
3,5,8-trihydroxy-6-methyl-4-{4,7,11,13-tetrahydroxy-5-methyl-2,9-dioxotetracyclo[8.4.0.0¹,¹².0³,⁸]tetradeca-3,5,7,10-tetraen-14-yl}-3,4-dihydro-2h-anthracene-1,9,10-trione
(2s,3r,11'r,12's)-2,11'-bis(3,4-dihydroxyphenyl)-4,6,7',12'-tetrahydroxy-2h-3',10'-dioxaspiro[1-benzofuran-3,5'-tricyclo[7.4.0.0²,⁶]tridecane]-1',6',8'-trien-4'-one
(2s,3s)-2-(2,4-dihydroxyphenyl)-3-[(2s,3s)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-3-yl]-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
6-{[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4-oxochromen-8-yl]oxy}-3,5-dihydroxy-4-(sulfooxy)oxane-2-carboxylic acid
C21H18O17S (574.0264698000001)
(2s,3r,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4-oxochromen-8-yl]oxy}-3,5-dihydroxy-4-(sulfooxy)oxane-2-carboxylic acid
C21H18O17S (574.0264698000001)